by Peter Ciszewski | May 20, 2018
Daniel de Boer, Founder and CEO of ProQR, discussuses Epidermolysis bullosa (EB), a group of genetic skin diseases that cause the skin to blister and erode very easily. In people with EB, blisters form in response to minor injuries or friction, such as rubbing...
by Peter Ciszewski | May 19, 2018
Yuval Cohen, PhD, CEO of Corbus discusses the role of inflammation in auto-immune diseases. Inflammation occurs when our immune system, designed to protect our bodies from external pathogens, is activated. Under normal circumstances, once it has been activated and the...
by Peter Ciszewski | May 18, 2018
Chris Garabedian discusses some of Xontogeny’s recent activity. Xontogeny is a biotech aggregator which supports the accelerated development of life science technologies in the pursuit of helping patients with serious...
by Peter Ciszewski | May 17, 2018
Rob Neville of Savara Pharmaceuticals discusses how his company engages advocacy groups in the disease they have clinical programs in, including PAP and Cystic...
by Peter Ciszewski | May 16, 2018
Seth Rotberg, 27, was diagnosed with Huntington’s Disease at age 20 and has since become an advocate for rare disease patients. He tells us about his experience dealing with his own diagnosis, and shares his advice for anyone dealing with a new disease diagnosis,...
